Valiant Laboratories Ltd.

₹59.17

1.5 (2.6%)

VALIANTLAB Share Price

Pharmaceuticals & Biotechnology

As on January 27, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 322 Cr

P/E Ratio-125.84

Dividend YieldN/A

Trendline Performance

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	58.71	Bullish
10-DMA	61.38	Bearish
20-DMA	66.03	Bearish
50-DMA	68.49	Bearish
100-DMA	76.44	Bearish
200-DMA	86.45	Bearish

Historical Performance

1 Year

-36.6%

3 Years

N/A

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023
Net Sales	1,334	1,821	3,339
Total Expenditure	1,381	1,905	2,988
Other Income	54	97	49
Operating Profit	8	13	400
Interest	2	1	3
Depreciation	21	20	16
Profit Before Tax	-15	-8	381
Consolidated Net Profit	-22	3	290
Adjusted EPS	---	---	8

Compounded Sales Growth

10 Years:-16.8

5 Years:-16.8

3 Years:-16.8

TTM:-6

Compounded Profit Growth

10 Years:-51.7

5 Years:-51.7

3 Years:-51.7

TTM:19

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:N/A

TTM:-34.4

Return on Equity

10 Years:N/A

5 Years:N/A

3 Years:8.3

last year:-0.5

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023
Share Capital	434	434	326
Total Reserves	1,909	1,934	679
Long-Term Borrowings	---	---	---
Total Non-Current Liabilities	1,069	767	617
Other Current Liabilities	18	16	33
Short Term Borrowings	169	14	---
Total Liabilities	4,009	3,427	2,130
Capital Work in Progress	1,558	426	7
Long Term Loans & Advances	40	244	136
Currents Investments	---	376	340
Short Term Loans and Advances	397	240	124
Total Current Assets	1,926	2,255	1,506
Total Assets	4,009	3,427	2,130
Adjusted Book Value	50	51	31

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of -125.84, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of -38.8%, indicating poor shareholder returns.
The stock carries a beta of 1.0, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹8 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹1334 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 656319.2

No. of Shares: 11092 (Approx)

Performance:-34.4%

P/L: ₹-343680.8

NIFTY Performance: 9.7%

1 day Top Gainers